Effect of mifepristone (25 mg) in treatment of uterine myoma in perimenopausal woman

Effect of mifepristone (25 mg) in treatment of uterine myoma in perimenopausal woman

Objectives: To evaluate the effect of Mifepristone (25 mg) on symptomatic myoma in perimenopausal women. Study Design: Open label clinical trial. Materials and Methods: Ninety three perimenopausal women of age 35-50 years having symptomatic myoma were selected from Gynecology OPD and given 25 mg Mif...

Full description

Bibliographic Details
Main Authors: Shikha Seth, Neeru Goel, Ekta Singh, A S Mathur, Garima Gupta
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2013-01-01
Series:Journal of Mid-Life Health
Subjects:
Anti-progesterone
medical treatment
mifepristone
myoma
Online Access:http://www.jmidlifehealth.org/article.asp?issn=0976-7800;year=2013;volume=4;issue=1;spage=22;epage=26;aulast=Seth

Internet

http://www.jmidlifehealth.org/article.asp?issn=0976-7800;year=2013;volume=4;issue=1;spage=22;epage=26;aulast=Seth

Similar Items